Paxlovid Side Effects: The Taste, the Timeline, and the Risk That Actually Matters

If you've been prescribed Paxlovid (nirmatrelvir/ritonavir) for COVID-19, you're probably wondering what side effects to expect.

The most talked-about one is the strange metallic or bitter taste that can show up while you're taking it. Diarrhea and other mild side effects can happen too, but they are usually manageable.

The bigger safety issue with Paxlovid is often not the side effects themselves. It is the drug interactions. Ritonavir affects how the body processes many medications, so some commonly used drugs may need to be stopped temporarily, adjusted, or monitored while you take Paxlovid.

Here's what to know about Paxlovid side effects, how long they usually last, when to call a clinician, and why your complete medication list matters before starting treatment.

TL;DR: Key Takeaways

• The most recognizable Paxlovid side effect is an altered, bitter, or metallic taste called dysgeusia.
• Diarrhea is another common side effect. Headache and nausea can also occur.
• Most common side effects are mild and improve after treatment ends.
• The most important safety issue with Paxlovid is its potential for serious drug interactions.
• Ritonavir can significantly increase or decrease levels of other medications, sometimes requiring a temporary medication change or additional monitoring.
• Paxlovid is taken twice daily for 5 days and should be started within 5 days of COVID-19 symptom onset when prescribed for eligible patients.
• Kidney function affects the dose. Current FDA labeling includes reduced dosing for moderate and severe renal impairment, including people receiving hemodialysis.
• COVID-19 rebound can happen after treatment, but rebound also occurs in people who do not take antivirals and is usually mild.
• Tell your clinician about every prescription, over-the-counter medication, supplement, and herbal product you take before starting Paxlovid.

Have COVID symptoms and want a clinician to review whether Paxlovid is appropriate for you? Book a $39 online urgent care visit with August AI. A US-licensed clinician can review your symptoms, medications, and risk factors and prescribe treatment when clinically appropriate. The visit does not guarantee a prescription, and medication costs are separate. Severe breathing problems, chest pain, confusion, or other emergency symptoms require in-person emergency care.

Common Paxlovid side effects: the strange taste is real

The side effect most people associate with Paxlovid is dysgeusia, which means a change in taste.

People describe it as metallic, bitter, sour, or simply unpleasant. It can make food and drinks taste different while you're taking the medication.

The FDA prescribing information lists dysgeusia and diarrhea among the most common adverse reactions reported with Paxlovid.

Altered or metallic taste

The taste change can start during treatment and is generally temporary. For many people, it improves after the 5-day course ends.

There is no specific medication required for the taste change. Some people find that sugar-free candy, mints, gum, or strongly flavored drinks make it easier to tolerate.

Other common side effects

Other side effects reported with Paxlovid include:

• Diarrhea
• Headache
• Nausea
• Changes in taste

Fatigue, body aches, congestion, and other symptoms may also occur while you're taking Paxlovid, but these can be difficult to separate from the COVID-19 infection itself.

The important point is that mild side effects do not automatically mean you should stop treatment. If you're having trouble tolerating Paxlovid, contact the clinician who prescribed it before making changes to the course.

Paxlovid can be taken with or without food.

For a comparison with another antiviral used for a different respiratory infection, see our guide on does Tamiflu work? The honest answer, and who it actually helps.

The bigger concern: Paxlovid drug interactions

The most important safety issue with Paxlovid is its interaction potential.

Paxlovid contains ritonavir, a strong CYP3A inhibitor. This means it can substantially change the amount of certain other medications in your bloodstream. Some interactions can increase the risk of serious or even life-threatening adverse effects. Others can reduce the effectiveness of Paxlovid itself.

That's why medication review is an important part of deciding whether Paxlovid is appropriate.

Statins

Some cholesterol-lowering medications interact with Paxlovid.

Simvastatin and lovastatin are particularly important because their concentrations can rise significantly when combined with ritonavir, increasing the risk of severe muscle injury.

Depending on the specific statin, a clinician may recommend temporarily stopping it or making another adjustment.

Do not assume that every statin should be stopped for the same amount of time. The plan depends on the medication you're taking and your overall situation.

Blood thinners

Some anticoagulants can interact with Paxlovid and increase bleeding risk.

Rivaroxaban, for example, has a significant interaction with ritonavir. Apixaban may also require a specific dose adjustment or other management strategy.

Warfarin is different and may require closer monitoring rather than simply being stopped.

Because anticoagulant decisions can have serious consequences, don't stop a blood thinner on your own.

Immunosuppressants

This interaction can be particularly important for people who have received an organ transplant.

Medications such as tacrolimus and cyclosporine can reach dangerously high concentrations when combined with strong CYP3A inhibitors.

Transplant patients may need individualized dosing, medication interruption, or close laboratory monitoring. Their transplant team or another clinician familiar with their immunosuppressive regimen should be involved.

Other medications that may interact

Paxlovid can interact with many other medications, including some used for:

• Heart rhythm problems
• Seizures
• Migraine
• Gout
• Blood pressure and heart conditions
• Anxiety and sleep disorders
• Cancer treatment
• HIV treatment
• Hormonal contraception
• Immunosuppression

The interaction list is extensive, and the details depend on the exact drug and dose.

Some medications are contraindicated with Paxlovid because the interaction can cause serious harm. Examples in the current FDA prescribing information include certain antiarrhythmics, ranolazine, alfuzosin, sildenafil when used for pulmonary arterial hypertension, oral midazolam, triazolam, and certain strong CYP3A inducers such as rifampin and St. John's wort.

This is why a complete medication review matters more than simply checking whether you take a "high-risk" medication.

Include prescriptions, over-the-counter medications, vitamins, supplements, and herbal products.

Paxlovid rebound: what it means

Some people notice COVID-19 symptoms returning after they initially improve. A new positive test can also occur after a negative result.

This is called COVID-19 rebound.

Current CDC guidance describes rebound as a recurrence of symptoms or a new positive test, often occurring about 3 to 7 days after the initial illness has resolved. Rebound can happen whether or not someone took Paxlovid. Symptoms are usually mild and resolve within a few days.

Randomized trial data have also found that viral rebound can occur with or without Paxlovid, so rebound is not considered evidence that the medication simply "failed."

What should you do if COVID symptoms return?

If symptoms return after you've improved:

• Follow current guidance to reduce contact with others while you're infectious.
• Monitor your symptoms.
• Contact your clinician if you're getting significantly worse or have concerns about your recovery.
• Seek urgent or emergency care for serious breathing problems, chest pain, confusion, or other severe symptoms.

A second course of Paxlovid is not routinely recommended just because rebound occurs. Your clinician can determine whether additional treatment is appropriate in a particular situation.

For a broader look at distinguishing COVID symptoms from gastrointestinal illness, see our guide on stomach bug or food poisoning? How to tell the difference.

Paxlovid and kidney disease

Kidney function matters when determining the Paxlovid dose.

The current FDA prescribing information recommends:

• Mild renal impairment: No dose adjustment is recommended.
• Moderate renal impairment, eGFR 30 to less than 60: A reduced Paxlovid dose is used.
• Severe renal impairment, eGFR below 30: A lower dose and lower dosing frequency are used, including for patients receiving hemodialysis.
• Hemodialysis: The dose should be timed in relation to dialysis as specified in the prescribing information.

So having kidney disease does not automatically mean you cannot take Paxlovid. It means the prescribing clinician needs your current kidney function to determine the appropriate regimen.

Do not use an old Paxlovid dosing chart from early in the pandemic. Renal dosing guidance has changed.

Paxlovid and liver disease

Mild or moderate hepatic impairment generally does not require a Paxlovid dose adjustment.

Paxlovid is not recommended for people with severe hepatic impairment. Ritonavir can also cause liver-related adverse effects, so a clinician may need to consider your liver history when deciding whether treatment is appropriate.

If you have significant kidney or liver disease, make sure the clinician prescribing Paxlovid knows about it.

For guidance on distinguishing COVID from another illness that may need different treatment, see our guide on stomach bug or food poisoning? How to tell the difference.

Who is Paxlovid intended for?

Paxlovid is not a routine treatment for every person who develops COVID-19.

Current CDC guidance recommends considering antiviral treatment for people with mild or moderate COVID-19 who have one or more risk factors for severe disease. Age is an important risk factor, particularly in adults over 65, and certain medical conditions and immunocompromising conditions can also increase risk.

Other factors a clinician may consider include:

• Older age
• Multiple chronic medical conditions
• Immunocompromising conditions
• Use of immunosuppressive medications
• Other factors associated with a higher risk of severe COVID-19

The decision is individualized. Being young and otherwise healthy generally means the potential benefit may be different from that in someone at higher risk for hospitalization.

When should Paxlovid be started?

Paxlovid should be started as soon as possible when it is indicated and within 5 days of symptom onset. The standard treatment course is 5 days.

The earlier an eligible high-risk patient starts treatment, the sooner the antiviral can begin working against viral replication.

Paxlovid is not intended to replace emergency care for someone who is already seriously ill.

For a comparison with antiviral timing for influenza, see our guide on when is it too late to take Tamiflu? What the 48-hour rule actually means.

How effective is Paxlovid?

The benefit of Paxlovid depends heavily on who is taking it.

In the original clinical trial involving unvaccinated adults at high risk for severe COVID-19, Paxlovid substantially reduced the risk of hospitalization or death when started early. Current CDC guidance cites an 87% reduction in the risk of hospitalization or death in that trial population.

Later real-world studies have also found benefit among people with prior immunity, although the size of the benefit varies by population and baseline risk.

That distinction matters. A medication that provides a meaningful reduction in hospitalization risk for a high-risk patient may offer much less absolute benefit to someone with a very low baseline risk.

The question is therefore not simply whether Paxlovid "works." It is whether the expected benefit for a particular patient outweighs the medication's potential risks and interaction burden.

When to contact a clinician

Most common Paxlovid side effects do not require emergency treatment.

Contact your clinician if:

• Side effects are persistent or difficult to tolerate.
• You're unsure whether one of your medications interacts with Paxlovid.
• You accidentally miss multiple doses.
• You develop new or worsening symptoms.
• COVID symptoms return after you initially improve.
• You have significant kidney or liver disease.
• You take several medications that require coordination.

Seek emergency medical care for symptoms such as:

• Difficulty breathing
• Chest pain or pressure
• Severe confusion or difficulty staying awake
• Bluish or gray lips, face, or skin
• Signs of a severe allergic reaction
• Severe or rapidly worsening illness

Severe muscle pain or weakness, particularly in someone taking a medication with a known Paxlovid interaction, also warrants prompt medical attention.

For quick evaluation of skin symptoms that may accompany illness, see our guide on rashes a photo visit can handle.

Conclusion

Paxlovid side effects are usually manageable. The metallic or bitter taste is the one people notice most, while diarrhea and other gastrointestinal symptoms can also occur.

The more important safety issue is the medication interaction profile. Ritonavir can dramatically change the levels of many other drugs, which is why your clinician needs a complete list of everything you take before prescribing Paxlovid.

Paxlovid is intended primarily for people with COVID-19 who are at higher risk of progressing to severe disease. When indicated, it should be started as soon as possible and within 5 days of symptom onset.

COVID-19 rebound can happen after treatment, but it also occurs without antiviral treatment and is usually mild. Rebound alone does not mean that the original treatment failed.

If you've been prescribed Paxlovid, the most useful thing you can do is make sure the prescriber knows your medications, supplements, kidney function, liver history, and other relevant health conditions before you take the first dose.